Papers: 10.1186/s13148-021-01002-y

https://doi.org/10.1186/s13148-021-01002-y

Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival

Cited by: 14
Author(s): Marta Cabezón, Roberto Malinverni, Joan Bargay, Blanca Xicoy, Sílvia Marcé, Ana Garrido, Mar Tormo, Leonor Arenillas, Rosa Coll, Josep Borrás, M.J. Jiménez, Montserrat Hoyos, David Valcárcel, Lourdes Escoda, Ferrán Vall-Llovera, Antoni García, Llorens Font, Elena Rámila, Marcus Buschbeck, Lurdes Zamora
Published: almost 6 years ago

Software Mentions 2